variation guidelines 2016
POST-REGISTRATION VARIATION GUIDELINES FOR
1 oct 2023 · This guideline is intended to provide information for submission of post-registration variation application by the registrations / marketing |
ASEAN Variation Guideline for Pharmaceutical Product Revision 1
Such amendments have to be approved by the Drug Regulatory Authority This guidance document is intended to provide supportive information on the requirements |
ASEAN Variation Guidelines For Pharmaceutical Products
This guidance document is intended to provide supportive information on the requirements for submission of a variation application to implement a change to a |
What is a variation in pharma?
Variation means any amendment to the terms of an authorisation to market a human medicine as well as any change to the summary of product characteristics and the documents forming the basis for a marketing authorisation.
In other words, any change that may have an impact on patient safety may be regarded as a safety variation.
Update to the reference safety information, that pertains to posology, special warnings and precautions, contraindications, undesirable effects and overdose.
COMMISSION DELEGATED REGULATION (EU) 2016/ 2251 - of 4
15.12.2016 The first type is variation margin which protects counterparties against exposures related to the current market value of their OTC derivative ... |
Guideline on process validation for finished products - information
21.11.2016 European Medicines Agency 2016. ... EMA/CHMP/CVMP/QWP/749073/2016. Page 2/15. This guideline replaces the note for guidance on process ... |
European Medicines Agency post-authorisation procedural advice
20.06.2022 Dec 2016. Commission Regulation (EC) No 1234/2008 ('the Variations Regulation') and the “Commission guidelines on the details of the various ... |
C 223 Official Journal
02.08.2013 726/2004 as well as in the Variations Regulation. In addition for the purpose of these guidelines |
ASEAN Common Technical Requirements (ACTR)
Jakarta ASEAN Secretariat |
Q&A on PSUSA Guidance Document for Assessors - update Oct 2017
31.10.2017 EMA/518909/2016 ... Q & A on PSUSA: Guidance document for assessors ... (i.e. they would warrant a recommendation of important variation of ... |
REGULATIONS
17.02.2021 Commission Delegated Regulation (EU) 2016/2251 (2) specifies ... exchange of variation margin for those contracts between the most systemic ... |
Harmonised Technical Guidance for eCTD Submissions in the EU
22.04.2016 For variations PSUSAs |
Implementation plan for the introduction of the safety features on the
29.06.2017 1. in case of applications with a CHMP opinion in March 2016 ... immediate packaging (see section B.II.e. of the Variation Guidelines). |
Practical questions and answers to support the implementation of
01.06.2016 Practical questions and answers to support the implementation of the variations guidelines1 in the ... European Medicines Agency 2016. |
ASEAN Variation Guidelines For Pharmaceutical Products
6 2 Any variations not yet listed in this guideline should be justified and decided by the Drug Regulatory Authority Appropriate reference can be made to: i EMA |
The GCC Guidelines for Variation Requirements_Ver_3_3pdf
Health Ministers' Council for GCC States The GCC Guidelines for Variation Requirements Version 3 3 Date of implementation 02/06/2016 Page 1 of 62 |
Practical questions and answers to support the implementation of
1 jui 2016 · implementation of the variations guidelines1 in the centralised procedure 1 European Medicines Agency, 2016 Reproduction is authorised |
Variations - European Commission - europaeu
22 jan 2016 · Regulatory Information 01/2016 - Variations - Article 57 database As of 1 February guideline on details of categories of variations 1 foresee |
Annex 10 - WHO World Health Organization
2016 WHO Expert Committee on Specifications for Pharmaceutical are provided in detail in the Guidelines on variations to a prequalified product (2) or other |
FDA Circular No 2016-017pdf - Food and Drug Administration
3 oct 2016 · as per the ASEAN Variation Guideline for MiV-PA32 Pharmaceutical Products under FDA Circular [Change in any part of the (primary) 2014- |
Administrative Order No 2016-0003 - Guidelines on the - FDA
FEB 15 2016 SUBJECT: Guidelines on the Unified Licensing Requirements and 1 Filing An application for LTO, whether initial, renewal, or variation, and |
GUIDELINES ON VARIATIONS TO A REGISTERED - RRFA
Revision Date: 8th July 2013 Review Due Date: 16th July 2016 Page iii of 70 Guidelines on Variations to a Registered Pharmaceutical Product CONTENTS |
APPENDIX 13 GUIDELINE ON MINOR VARIATION APPLICATIONS
15 jan 2019 · This document describes the requirements of a Minor Variation Application (MIV) submitted for an existing registered chemical drug product in |